The current study shows that GPX4 inhibition strongly induces ferroptosis of mesenchymal-like cancer cells compared with its negligible effect on epithelioid cancer cells, leading to the speculation that highly mesenchymal-like cells are more susceptible to ferroptosis, which may be related to high baseline transcription of ZEB1 in mesenchymal-like cells. This evidence concerns the gene GPX4 and cancer.